BUSINESS
GSK takes the flexible approach to Asian growth
GlaxoSmithKline's approach to growing its business across the Asia-Pacific region recognises the need for distinct strategies tailored to each national market. This may involve a blend of price cuts, regional co-promotion partnerships and targeted M&A deals. The company also realises that innovation can come from any source.
- S*BIO sticks to the book on its road to market
- Attracting brains and the big bucks
- Vietnam: significant investment opportunities for foreign pharma firms
- Chinese dealmaking
R&D/BIOTECH
Punching above their weight
Take a tour around the Asia-Pacific region’s biotech hotspots and you’ll discover markets teeming with entrepreneurial spirit and innovative R&D.
CrystalGenomics, a South Korean drug discovery player, hopes to build on a position of strength as its partnerships grow.
- Natural toxin just the tonic for CK Life Sciences
- Rexbio sets sights on novel approach to pancreatic cancer
- MerLion builds on its strengths as it looks to new areas
THE VIEW FROM ASIA
Emerging and trailblazing
Smart companies know that to do successful business in Asia means being a polyglot, flexible operation able quickly to meet the varying demands of a highly diverse set of languages, cultures and healthcare needs and systems. Portfolios and marketing practices – and sometimes prices – need to be adjusted accordingly. Read more...
The Scrip Asia 100
NATIONAL MARKETS
Bloc building
ASEAN nations know that they need to get their regulatory systems in line before they can compete on the global stage. Market harmonisation would pave the way for better access to medicines and ease the concerns of innovator pharma.
More National MarketsCLINICAL TRIALS
Where strong relationships count
The Chinese market for clinical trials is growing at an enormous pace. Local and foreign CROs need to make the right connections if they are to keep up.
- Reviving Japan's clinical trial system
- CROs find a Seoul mate in South Korea
- Taiwanese studies on the up too
Scrip is the single source for all pharmaceutical business intelligence.
Strengthen your commercial knowledge with full news and analysis. Sign up for a free 5-day trial now>
Latest news from scripnews.com
Sponsors
 |
 |
 |
 |